A higher percentage of the at-risk NASH group were white (67% vs. 59%, p = < 0.0001) and had T2D (59% vs. 44%, p = 0.0039) as well as higher measures of AST, ALT, γ-glutamyl transferase (GGT), FPG, HbA1c, triglycerides, and total cholesterol compared to the non-at-risk NASH population. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.